Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline ...
Conduit Pharmaceuticals advances its pipeline with key progress in preclinical lupus studies for AZD5658, Phase IIa trial design for AZD1656, formulation optimization, and IP expansion, positioning th ...
Quanterix Corporation (NASDAQ:QTRX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 17, 2025 Quanterix Corporation misses on earnings expectations. Reported EPS is $-0.3 ...